About Sompharmaceuticals

About company

Sompharmaceuticals is a Swiss biopharmaceutical company based at the Biopôle in Epalinges-Lausanne, Switzerland. Their focus is on developing novel anti-tumour somatostatin analogue (SSA) peptide medicines and diagnostics for patients with rare diseases, which have unmet medical needs and major market opportunities, including growth hormone producing pituitary brain tumours (acromegaly) and malignant neuroendocrine hormone producing intestinal and pancreatic tumours (NETs) that are resistant or poorly controlled with currently available SSA treatments, octreotide and lanreotide.